Health Care 

Historic St. Louis NEC Baby Formula Trial Results in Nearly $500 Million Judgment

A closely watched necrotizing enterocolitis (NEC) baby formula bellwether trial culminated in a $495 million judgment Friday against Abbott Laboratories, a verdict that could affect many other lawsuits awaiting litigation...

Historic St. Louis NEC Baby Formula Trial Results in Nearly $500 Million Judgment
Roche showcases solutions for laboratories of the future at the Association for Diagnostics & Laboratory Medicine 2024 Clinical Lab Expo

Roche (SIX: RO, ROG; OTCQX: RHHBY) will showcase a laboratory of the future exhibit at the 2024 Association for Diagnostics & Laboratory Medicine (ADLM) Scientific Meeting and Clinical Lab Expo, July 28 through August...

Roche showcases solutions for laboratories of the future at the Association for Diagnostics & Laboratory Medicine 2024 Clinical Lab Expo
Brooks PathFinder™ System selected by Lifeblood for Sample Management

Brooks Automation, a global leader in innovative design, manufacture and commercialization of robotic automation for laboratories, is proud to announce its successful appointment as an official vendor for Lifeblood...

Brooks PathFinder™ System selected by Lifeblood for Sample Management
AOPO Receives 2024 Power of Associations Gold Award for Historically Black Colleges and Universities (HBCU) & OPO Task Force

The Association of Organ Procurement Organizations (AOPO) has been recognized with a Power of Associations Gold Award by the American Society of Association Executives (ASAE) for its successful Historically Black Colleges...

AOPO Receives 2024 Power of Associations Gold Award for Historically Black Colleges and Universities (HBCU) & OPO Task Force
BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen Genotyping

BillionToOne, a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, is thrilled to announce a new publication that shows cfDNA analysis is highly sensitive and...

BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen Genotyping
Astellas Receives Positive CHMP Opinion for Zolbetuximab in Combination with Chemotherapy for Treatment of Advanced Gastric and Gastroesophageal Junction Cancer

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that on July 26, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted...

Astellas Receives Positive CHMP Opinion for Zolbetuximab in Combination with Chemotherapy for Treatment of Advanced Gastric and Gastroesophageal Junction Cancer
Astellas Receives Positive CHMP Opinion for PADCEV™ (enfortumab vedotin) in combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive...

Astellas Receives Positive CHMP Opinion for PADCEV™ (enfortumab vedotin) in combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Annual Friar Fight to End Duchenne Golf Tournament Celebrates 40 Years

For 40 years, residents of Grand Rapids, Michigan, have supported the mission of Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), by...

Annual Friar Fight to End Duchenne Golf Tournament Celebrates 40 Years
ASAP Translate Launches Dynamic Website for Optimal User Experience

ASAP Translate, a leader in prompt, precise, and top-tier translation services, proudly announces the launch of its newly redesigned website aimed at enhancing user experience and facilitating seamless global communication.

ASAP Translate Launches Dynamic Website for Optimal User Experience
U.S. FDA Approves LEQSELVI™ (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries or associate companies) today announced that the U.S. Food and Drug...

U.S. FDA Approves LEQSELVI™ (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata
ZUMBA FITNESS AND SAMSUNG HEALTH LAUNCH DYNAMIC PARTNERSHIP TO ELEVATE GLOBAL FITNESS AND WELLBEING

Zumba®, the world-renowned dance fitness brand, and Samsung Health, a leading innovator in digital health solutions, are thrilled to announce an exciting new partnership. This collaboration brings Zumba's iconic dance...

ZUMBA FITNESS AND SAMSUNG HEALTH LAUNCH DYNAMIC PARTNERSHIP TO ELEVATE GLOBAL FITNESS AND WELLBEING
Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2024 on Wednesday, July 31, 2024, after the market closes.

Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024
RetiSpec Closes $10M USD to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer's Disease

TORONTO, July 26, 2024 /PRNewswire/ - RetiSpec Inc.,  an innovator in AI-driven eye diagnostics for brain health, announced the successful closing of its $10M USD Series A financing. This funding will enable RetiSpec to...

RetiSpec Closes $10M USD to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer's Disease
Toronto Raptors and Canada Basketball Star RJ Barrett Teams with Aires Tech As Newest #AiresAthletes Partner

American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) ("Aires Tech" or "Aires"), a pioneer in cutting-edge technology designed to protect against electromagnetic radiation (EMF) and optimize human health, welcomes Toronto Raptors...

Toronto Raptors and Canada Basketball Star RJ Barrett Teams with Aires Tech As Newest #AiresAthletes Partner
CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer

CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced that the European Commission (EC) has approved...

CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer
TMRW Life Sciences Offers 2024 United States Summer Olympic & Paralympic Teams Free Cryostorage for Frozen Embryos, Eggs & Sperm at State-of-the-Art Biorepository

TMRW Life Sciences (TMRW), a fertility technology company setting a new standard of care in fertility storage, today announced that it is providing free cryostorage for frozen sperm, eggs and embryos for all members of the...

TMRW Life Sciences Offers 2024 United States Summer Olympic & Paralympic Teams Free Cryostorage for Frozen Embryos, Eggs & Sperm at State-of-the-Art Biorepository
Delta Dental of California Expands Access to DeltaVision® in Partnership with VSP® Vision Care

Delta Dental of California and Affiliates, the leading dental insurance provider, in partnership with VSP® Vision Care, the nation's first not-for-profit vision benefits company, has announced the expansion of...

Delta Dental of California Expands Access to DeltaVision® in Partnership with VSP® Vision Care
Piramal Pharma Limited Announces Consolidated Results for Q1FY25

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated results for the First Quarter (Q1) ended 30th June 2024.

Piramal Pharma Limited Announces Consolidated Results for Q1FY25
Avantor® Reports Second Quarter 2024 Results

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its second fiscal...

Avantor® Reports Second Quarter 2024 Results
Harbour BioMed to Present the Latest Progress of the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, announced...

Harbour BioMed to Present the Latest Progress of the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024
U.S. FDA Approves LEQSELVI™ (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries or associate companies) today announced that the U.S. Food and Drug...

U.S. FDA Approves LEQSELVI™ (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata
Mercy to Open Three New Primary Care Facilities in Arkansas

Mercy will continue expanding its Arkansas footprint to make care more convenient and reach additional consumers where they already are with three new Mercy Primary Care locations in former Walmart Health centers inside...

Mercy to Open Three New Primary Care Facilities in Arkansas
PANTHERx®Rare Partnering with ITF Therapeutics LLC for U.S. Distribution of DUVYZAT™

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce it is partnering with ITF Therapeutics LLC for the U.S. distribution of...

PANTHERx®Rare Partnering with ITF Therapeutics LLC for U.S. Distribution of DUVYZAT™
CoachCare Announces $48 Million Investment Led By Integrity Growth Partners

CoachCare, a leading remote patient monitoring (RPM) and virtual care management company, today announced a $48 million strategic growth investment led by Integrity Growth Partners ("IGP"), a leading growth investment firm...

CoachCare Announces $48 Million Investment Led By Integrity Growth Partners
20 Years after Landmark FDA Approval, SynCardia Remains World's Only Commercially Approved Total Artificial Heart

Nearly twenty years ago, the SynCardia Total Artificial Heart became the first total artificial heart to receive commercial approval from the U.S. Food & Drug Administration (FDA). Since then, a number of experimental...

20 Years after Landmark FDA Approval, SynCardia Remains World's Only Commercially Approved Total Artificial Heart
PANTHERx Rare Appoints Bansi Nagji as CEO; Rob Snyder appointed Executive Chair

PANTHERx Rare, one of the nation's largest and fastest growing rare disease specialty pharmacies, today announced the appointment of Bansi Nagji as CEO effective August 1, 2024. In this role, Mr. Nagji will continue...

PANTHERx Rare Appoints Bansi Nagji as CEO; Rob Snyder appointed Executive Chair
HAIR LOSS AWARENESS MONTH 2024 "TIME EQUALS FOLLICLES"

As the summer winds down, August brings an essential focus to Hair Loss Awareness Month, highlighting the widespread issue of hair loss and the latest scientific breakthroughs. With over 80 million American men and women...

HAIR LOSS AWARENESS MONTH 2024 "TIME EQUALS FOLLICLES"
Lung Cancer Research Foundation Joins Lung Cancer Advocacy Organizations and 23andMe to Launch Lung Cancer Genetics Study to Advance Research

The Lung Cancer Research Foundation (LCRF), in collaboration with 23andMe Holding Co., a leading genetic health and biopharmaceutical company, and 20 lung cancer advocacy organizations, today announced a new study to help...

Lung Cancer Research Foundation Joins Lung Cancer Advocacy Organizations and 23andMe to Launch Lung Cancer Genetics Study to Advance Research
LA ROCHE-POSAY IS THE OFFICIAL SUNSCREEN PARTNER OF THE MUBADALA CITI DC OPEN

La Roche-Posay, the worldwide expert in advanced UV protection, is thrilled to announce its partnership as the official sunscreen partner of the Mubadala Citi DC Open. Research suggests sunburns are highly tied to physical...

LA ROCHE-POSAY IS THE OFFICIAL SUNSCREEN PARTNER OF THE MUBADALA CITI DC OPEN
OCuSOFT® Introduces NEW OCuSOFT® Retaine® Allergy Artificial Tears for Eye Allergy Itch Relief

OCuSOFT Inc., a privately-held eye and skin care company with an established reputation for innovation in eyelid hygiene is pleased to announce the availability of NEW OCuSOFT® Retaine® Allergy original prescription...

OCuSOFT® Introduces NEW OCuSOFT® Retaine® Allergy Artificial Tears for Eye Allergy Itch Relief
Renew Biotechnologies Welcomes Steven Abbott as Chief Operating Officer to Lead Wasatch BioLabs' Transition to Commercial Operations

Renew Biotechnologies, a leading biotech company dedicated to pioneering NGS-based diagnostic solutions, appoints Steven Abbott as Chief Operating Officer (COO). Mr. Abbott brings extensive experience in genomics and...

Renew Biotechnologies Welcomes Steven Abbott as Chief Operating Officer to Lead Wasatch BioLabs' Transition to Commercial Operations
AbbaDox and Merge Partner to Enhance Radiology Workflow Solutions

AbbaDox, a leading provider of cloud-based healthcare solutions, is pleased to announce a strategic relationship with Merge Healthcare Solutions to deliver an enhanced suite of radiology workflow solutions.

AbbaDox and Merge Partner to Enhance Radiology Workflow Solutions
HILL'S PET NUTRITION RELEASES 2024 STATE OF SHELTER PET ADOPTION REPORT

Hill's Pet Nutrition, a leading partner in animal welfare, today released new findings from the 2024 Hill's Pet Nutrition State of Shelter Pet Adoption Report. The research, which provides insights from a...

HILL'S PET NUTRITION RELEASES 2024 STATE OF SHELTER PET ADOPTION REPORT
The Medical University of South Carolina Becomes First in South Carolina to Adopt MOLLI Surgical's Advanced Breast Cancer Technology

MUSC Hollings Cancer Center, an NCI-designated cancer center within the Medical University of South Carolina (MUSC), the state's only comprehensive academic health system, is partnering with MOLLI Surgical to adopt the...

The Medical University of South Carolina Becomes First in South Carolina to Adopt MOLLI Surgical's Advanced Breast Cancer Technology
Highlands and Paradigm improve access to cancer care options in northwest Arkansas, increasing clinical trial participation by 45%

Paradigm and Highlands Oncology announce promising results from their ongoing collaboration, demonstrating a 45% increase in the number of patients enrolled in clinical trials. The achievement aligns with the objectives to...

Highlands and Paradigm improve access to cancer care options in northwest Arkansas, increasing clinical trial participation by 45%
Celebrate "Every Breath, Every Story" During Pulmonary Fibrosis Awareness Month in September

September is Pulmonary Fibrosis Awareness Month, presented by the Pulmonary Fibrosis Foundation (PFF) to drive awareness of pulmonary fibrosis (PF) and interstitial lung disease (ILD). There are more than 200 types of...

Celebrate "Every Breath, Every Story" During Pulmonary Fibrosis Awareness Month in September
Lilly Confirms Date and Conference Call for Second-Quarter 2024 Financial Results Announcement

Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2024 financial results on Aug. 8, 2024. Lilly will also conduct a conference call that day with the investment community and media to further detail the...

Lilly Confirms Date and Conference Call for Second-Quarter 2024 Financial Results Announcement
Pharmacy Technician Educators Council Conference Sets New Attendance Record

The Pharmacy Technician Educators Council (PTEC) proudly announces the successful conclusion of its annual conference, held this month in the vibrant city of Charleston, South Carolina. The event marked a significant...

Pharmacy Technician Educators Council Conference Sets New Attendance Record
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast

Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its second quarter 2024 results on...

Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast
Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption

Veeva Systems (NYSE: VEEV) today revealed that targeted pre-launch scientific outreach maximizes medical affairs teams' impact on treatment adoption in the latest Veeva Pulse Field Trends Report. The analysis shows...

Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption
Veronica Beard and Breakthrough T1D Announce Veronica Beard Gives Back Partnership

Today, Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, and American ready-to-wear brand Veronica Beard, known for cool, classic, wardrobe essentials for women...

Veronica Beard and Breakthrough T1D Announce Veronica Beard Gives Back Partnership
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration

Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the DxI 9000 Immunoassay Analyzer* was honored during Premier, Inc.'s annual supplier Innovation Celebration at its 2024 Breakthroughs...

Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration
Alamar Biosciences Achieves ISO 13485 Certification, Demonstrating its Commitment to Quality and Safety

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announces that it has successfully achieved ISO 13485:2016 certification. This internationally recognized...

Alamar Biosciences Achieves ISO 13485 Certification, Demonstrating its Commitment to Quality and Safety
AI Medical Coding: MediCodio's Compliance Strength - ISO/IEC 27001:2022 and HIPAA Certificate

MediCodio, a reliable AI medical coding solutions provider is proud to announce its acquisition of two prestigious compliance certificates: ISO/IEC 27001:2022 and HIPAA Compliance. These certifications reinforce...

AI Medical Coding: MediCodio's Compliance Strength - ISO/IEC 27001:2022 and HIPAA Certificate
Neurophet to launch total solution for AD treatments 'Neurophet AQUA AD' at AAIC 2024

Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its participation in the Alzheimer's Association International Conference (AAIC 2024) which will be held in Philadelphia, U.S.A.

Neurophet to launch total solution for AD treatments 'Neurophet AQUA AD' at AAIC 2024
TrainingPeaks Muscles Up with New Strength Feature

TrainingPeaks, the industry-leading training app for endurance coaches and athletes, today announced the release of the Strength Workout Builder, a new feature that allows coaches to save time, look pro, and gain valuable...

TrainingPeaks Muscles Up with New Strength Feature
Second Heart Assist Announces an Impressive Successful Completion of a First-In-Human Case Study in Central America with its Whisper™ Device

Utah-based Second Heart Assist Inc., announced today the successful completion of the company's first Central American case to evaluate the performance of its Whisper™ percutaneous mechanical circulatory device,...

Second Heart Assist Announces an Impressive Successful Completion of a First-In-Human Case Study in Central America with its Whisper™ Device
ITF Therapeutics LLC Announces U.S. Commercial Availability of DUVYZAT™ (givinostat) for Treatment of Patients With Duchenne Muscular Dystrophy

ITF Therapeutics LLC, the U.S.-based rare disease commercial arm of Italfarmaco, today announced the U.S. commercial launch of DUVYZAT™ (givinostat), a histone deacetylase inhibitor, for the treatment of patients six years...

ITF Therapeutics LLC Announces U.S. Commercial Availability of DUVYZAT™ (givinostat) for Treatment of Patients With Duchenne Muscular Dystrophy
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024

Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it will...

Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024
Peijia Medical's Licensing Partner, JenaValve Technology, Inc., is Expected to be Acquired by Edwards Lifesciences

Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, today commented on the expected acquisition of...

Peijia Medical's Licensing Partner, JenaValve Technology, Inc., is Expected to be Acquired by Edwards Lifesciences
Brighton Health Plan Solutions, LLC Names Jeremy Schoettle Chief Financial Officer

Brighton Health Plan Solutions, LLC, a national healthcare enablement company and third-party administrator, has named Jeremy Schoettle chief financial officer. He joins the company following the retirement of the...

Brighton Health Plan Solutions, LLC Names Jeremy Schoettle Chief Financial Officer
New Study Evaluates Use of the Nerivio® REN Wearable for Treatment of Migraine in Children Under the Age of 12

Theranica, a neuromodulation therapeutics company, today announced that Annals of the Child Neurology Society has published results from a prospective real-world evidence study evaluating the safety and efficacy of remote...

New Study Evaluates Use of the Nerivio® REN Wearable for Treatment of Migraine in Children Under the Age of 12
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer

DOMA Perpetual Capital Management LLC today sent a letter to the Board of Directors of InMode (NYSE: INMD) urging the Board to execute a 40% tender offer of the stock.

DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer
Fresh Thyme Market Announces Winner of Its Official 10th Birthday Cake Contest

Fresh Thyme Market, a full-service, better-for-you natural grocer with 70 stores in 10 states throughout the Midwest, is proud to announce the winner of its 10th Birthday Cake Contest in celebration of the company's...

Fresh Thyme Market Announces Winner of Its Official 10th Birthday Cake Contest
Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World

Analog Devices, Inc. (Nasdaq: ADI), a global semiconductor leader, and Flagship Pioneering, the bioplatform innovation company, today announced a strategic alliance to accelerate the development of a fully digitized...

Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World
SOL LABS Introduces Two New Innovative Sun Protection Solutions

SOL LABS, a pioneering name in sun care, proudly announces the launch of two groundbreaking products designed to redefine sun protection on-the-go and elevate eco-conscious practices in skincare. Building upon the success...

SOL LABS Introduces Two New Innovative Sun Protection Solutions
Options Medical Weight Loss Reports Robust Revenue Growth, Plans for Clinic Expansion

Options Medical Weight Loss, a Thurston Group portfolio company, today announced it achieved significant revenue growth of 80 percent in the first half of the year, and continues its trajectory for notable expansion. With...

Options Medical Weight Loss Reports Robust Revenue Growth, Plans for Clinic Expansion
BioIVT to Highlight its Integral Role in Drug and Diagnostic Discovery and Development in addition to Neuroscience Research at Premier Life Science Events

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced it will attend two leading industry conferences focused on research and developments for both...

BioIVT to Highlight its Integral Role in Drug and Diagnostic Discovery and Development in addition to Neuroscience Research at Premier Life Science Events
Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company will report its second quarter...

Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024
New Studies Validate the Value of Brainomix AI Technology Across US Stroke Networks

Brainomix, a pioneer in artificial intelligence (AI) imaging solutions, announced new data from studies that were presented this week at the US-based Society of Neurointerventional Surgery's (SNIS) Annual Meeting in...

New Studies Validate the Value of Brainomix AI Technology Across US Stroke Networks
Astrana Health Enters Definitive Agreement to Acquire Collaborative Health Systems

Astrana Health, Inc. ("Astrana"), together with its subsidiaries and affiliated entities ("the Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver...

Astrana Health Enters Definitive Agreement to Acquire Collaborative Health Systems
LEAD Sports and Health Tech Partners Launches LEAD ONE, a Direct Investment Vehicle Targeting Pre-Seed Companies

LEAD Sports and Health Tech Partners (LEAD), a globally renowned sports and health tech venture corporation, today unveiled LEAD ONE, a new direct, pre-seed investment vehicle.

LEAD Sports and Health Tech Partners Launches LEAD ONE, a Direct Investment Vehicle Targeting Pre-Seed Companies
Valcare Medical, Inc. Expands AMEND TS EU Pilot Study to Italy

Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, announces the expansion of the AMEND™ TS EU Pilot Study to Italy. The Italian Ministry of Health has approved the extension to include...

Valcare Medical, Inc. Expands AMEND TS EU Pilot Study to Italy
Ractigen Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to RAG-18 for the treatment of Duchenne Muscular Dystrophy

Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to RAG-18,...

Ractigen Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to RAG-18 for the treatment of Duchenne Muscular Dystrophy
Lehigh Valley Health Network Partners with Blue Zones to Transform Health of the Region

Lehigh Valley Health Network (LVHN) announces the next step of its partnership with Blue Zones, an initiative that uses an evidence-based approach to improve community well-being, resilience and economic vitality.

Lehigh Valley Health Network Partners with Blue Zones to Transform Health of the Region
AbbVie Reports Second-Quarter 2024 Financial Results

AbbVie (NYSE:ABBV) announced financial results for the second quarter ended June 30, 2024.

AbbVie Reports Second-Quarter 2024 Financial Results
Syndax to Announce Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 1, 2024

Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will report its second quarter 2024 financial results and...

Syndax to Announce Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 1, 2024
Beltone Ranked One of America's Best Midsize Employers 2024 by Forbes

Beltone, one of America's top rated hearing care providers, was recognized by Forbes as one of America's Best Midsize Employers 2024 in the Health Care Equipment & Services Industry for the second year in a...

Beltone Ranked One of America's Best Midsize Employers 2024 by Forbes
Labcorp Declares Quarterly Dividend

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be...

Labcorp Declares Quarterly Dividend
The Caris Precision Oncology Alliance Welcomes The University of Mississippi Medical Center

Caris Life Sciences®(Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today that The University of Mississippi Medical Center (UMMC) has joined the Caris Precision Oncology...

The Caris Precision Oncology Alliance Welcomes The University of Mississippi Medical Center
Bio-Thera Solutions Initiates Integrated Phase I / Phase III Clinical Trial for BAT3306, a Proposed Biosimilar of Keytruda® (Pembrolizumab)

Bio-Thera Solutions Inc. (688177: SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today announced that dosing has recently begun in an integrated Phase I /...

Bio-Thera Solutions Initiates Integrated Phase I / Phase III Clinical Trial for BAT3306, a Proposed Biosimilar of Keytruda® (Pembrolizumab)
West Announces Second-Quarter 2024 Results

West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2024 and updated full-year 2024 financial guidance.

West Announces Second-Quarter 2024 Results
Leading Alzheimer's Expert Joins T3D Therapeutics' Scientific Advisory Board

T3D Therapeutics, Inc., a clinical stage drug development company engaged in the development of a new orally administered treatment for Alzheimer's disease (AD), today announced that Dr. Robert Alexander has joined the...

Leading Alzheimer's Expert Joins T3D Therapeutics' Scientific Advisory Board
The Kardashians Take Longevity Test that Reveals Biological Age in 'The Kardashians' Upcoming Season Finale

The highly anticipated season finale of Hulu's 'The Kardashians,' releasing at 12:00am ET on July 25, 2024, features the celebrity family exploring cutting-edge health interventions focused on longevity. During...

The Kardashians Take Longevity Test that Reveals Biological Age in 'The Kardashians' Upcoming Season Finale
Select Medical Holdings Corporation Announces Pricing of Concentra Group Holdings Parent, Inc. Initial Public Offering

Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) and Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE: CON), a wholly owned subsidiary of Select Medical, today announced the pricing of...

Select Medical Holdings Corporation Announces Pricing of Concentra Group Holdings Parent, Inc. Initial Public Offering
Pioneering Single Cell Kidney Atlas Developed by Children's Hospital of Philadelphia and Penn Medicine Researchers Sheds Light on Potential Treatments

Researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania revealed the most extensive single cell atlas of the human kidney, capturing the...

Pioneering Single Cell Kidney Atlas Developed by Children's Hospital of Philadelphia and Penn Medicine Researchers Sheds Light on Potential Treatments
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2024 Financial Results

Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2024 on Wednesday, July 31 at 9 a.m., ET. The company will issue a news release...

Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2024 Financial Results
Brooks Automation to Showcase Innovative Hybrid Lab Automation Solutions at the Association for Diagnostics and Laboratory Medicine Conference (ADLM) July 30-August 1 in Chicago

Brooks Automation is excited to announce its participation in the upcoming Association for Diagnostics and Laboratory Medicine Conference in Chicago next week. Attendees are invited to Brooks booth #3839 to see the debut...

Brooks Automation to Showcase Innovative Hybrid Lab Automation Solutions at the Association for Diagnostics and Laboratory Medicine Conference (ADLM) July 30-August 1 in Chicago
Introducing Nurse Daisy: Revolutionizing Healthcare with Innovative Technology

In response to the pressing challenges facing healthcare today, BUDS Technology is launching Nurse Daisy as a groundbreaking solution designed to enhance patient experiences through advanced technology. Nurse Daisy...

Introducing Nurse Daisy: Revolutionizing Healthcare with Innovative Technology
The Cigna Group Declares Quarterly Dividend

The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.40 per share of its common stock, payable on September 19, 2024 to shareholders of record as of the close of business on September...

The Cigna Group Declares Quarterly Dividend
Jackson State University receives National Academy of Inventors' Founders Award: A notable first for HBCUs and Mississippi

Jackson State University (JSU) proudly announces its historic recognition as the recipient of the prestigious Founders Award from the National Academy of Inventors (NAI). This achievement makes JSU the first Historically...

Jackson State University receives National Academy of Inventors' Founders Award: A notable first for HBCUs and Mississippi
GLOBE LIFE INC. REPORTS SECOND QUARTER 2024 RESULTS

Globe Life Inc. (NYSE: GL) reported today that for the quarter ended June 30, 2024, net income was $2.83 per diluted common share, compared with $2.24 per diluted common share for the year-ago quarter. Net operating income...

GLOBE LIFE INC. REPORTS SECOND QUARTER 2024 RESULTS
Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast

Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2024 earnings which ended on June 30, 2024, on Tuesday, August 6, 2024, after the market closes.

Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast
U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental Biologics License Application (sBLA) for BRINEURA® (cerliponase alfa)...

U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease
With all Eyes on the Olympics, Will We Also See More Younger Athletes Undergoing Hip or Knee Replacement?

As the world trains its eyes on the upcoming Olympic games, it is important to recognize that all young elite athletes could one day face total hip or total knee replacement. Although we may think of someone of 65 as a...

With all Eyes on the Olympics, Will We Also See More Younger Athletes Undergoing Hip or Knee Replacement?
Nicklaus Children's Hospital Included in Newsweek's List of America's Best Children's Hospitals 2024

Nicklaus Children's Hospital has been included in Newsweek's list of America's Best Children's Hospitals 2024. Nicklaus Children's is the most-ranked hospital within the state of Florida with...

Nicklaus Children's Hospital Included in Newsweek's List of America's Best Children's Hospitals 2024
Reignite Your Fitness Goals: 5 Key Tips from NUTRISHOP®

It's mid-year already. How are those fitness goals coming along? Did you give up or get off track? Don't worry. You're not alone. Studies show most people don't stick to their New Year's resolutions,...

Reignite Your Fitness Goals: 5 Key Tips from NUTRISHOP®
30 Days to Greater Impact: Voiceitt's Free Trial Empowers Therapists to Help Clients with Non-Standard Speech

Voiceitt, the Israel-based leader in speech recognition technology for non-standard speech, today announced the opportunity for clinicians, educators, and customers to expand their impact through the launch of...

30 Days to Greater Impact: Voiceitt's Free Trial Empowers Therapists to Help Clients with Non-Standard Speech
Jessica Franson named SIA's 40 Under 40

GetMed Staffing proudly announces that Jessica Franson, Director of Nursing and Allied, has been recognized by Staffing Industry Analysts' (SIA) 2024 40 under 40 list.

Jessica Franson named SIA's 40 Under 40
RADY CHILDREN'S HOSPITAL TEAMSTERS END ULP STRIKE, DEMAND HOSPITAL RETURN TO NEGOTIATIONS

The following is a statement from Katie Langenstrass, Executive Director of United Nurses of Children's Hospital (UNOCH) Teamsters Local 1699, on the end of the unfair labor practice strike at Rady Children's...

RADY CHILDREN'S HOSPITAL TEAMSTERS END ULP STRIKE, DEMAND HOSPITAL RETURN TO NEGOTIATIONS
AUTISM SPEAKS TO HONOR TALLULAH WILLIS AT LOS ANGELES GALA

Autism Speaks, the largest autism advocacy group dedicated to creating an inclusive world for all individuals with autism spectrum disorder throughout their lifespan, is hosting its reimagined Los Angeles Gala at the...

AUTISM SPEAKS TO HONOR TALLULAH WILLIS AT LOS ANGELES GALA
SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today that OncoHelix, an internationally recognized research and diagnostics laboratory for...

SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix
Soterix Medical Announces FDA 510(k) Clearance of MEGA-IOM Intraoperative Neuromonitoring System

Soterix Medical Inc., the global leader in stimulation and synergistic monitoring technologies, announced today it has received a 510(k) clearance from the U.S. Food & Drug Administration for its Intraoperative...

Soterix Medical Announces FDA 510(k) Clearance of MEGA-IOM Intraoperative Neuromonitoring System
Loopback Analytics Teams Up with Loma Linda University Health to Enhance Specialty Pharmacy Services

Loopback Analytics, a leading provider of data analytics and market access services for health systems' specialty pharmacy programs, is pleased to announce its collaboration with Loma Linda University Health, a...

Loopback Analytics Teams Up with Loma Linda University Health to Enhance Specialty Pharmacy Services
New Jersey Mental Health Company AspireNJ Youth Launches Healing Summer Camp

High demand for mental health services introduces therapeutic services for high school students Hackensack, N.J.- July 20, 2024- AspireNJ, a mental health services company has launched Healing Hooves- a therapeutic mental...

New Jersey Mental Health Company AspireNJ Youth Launches Healing Summer Camp
American Osteopathic Association Installs Teresa Hubka, DO, as 128th President

Teresa A. Hubka, DO, FACOOG, FACOG, CS, was installed Saturday as President of the American Osteopathic Association (AOA), the nation's premier osteopathic medical organization representing more than 197,000...

American Osteopathic Association Installs Teresa Hubka, DO, as 128th President
Microsoft collaborates with Mass General Brigham and University of Wisconsin-Madison to further advance AI foundation models for medical imaging

Microsoft Corp. on Wednesday announced collaborations with leading academic medical systems Mass General Brigham and the University of Wisconsin School of Medicine and Public Health along with its partnering health system,...

Microsoft collaborates with Mass General Brigham and University of Wisconsin-Madison to further advance AI foundation models for medical imaging